{"id":"7c15318e-087a-4e6c-8f46-f1a42dcac2ff","arxiv_id":"2601.13577","paper_version":1,"verdict":"ACCEPT","confidence":"HIGH","novelty_score":3.0,"correctness_risk":"low","formal_verification":"none","parameter_count":1,"one_line_summary":"A review of large energy acceptance beam delivery systems for proton therapy, arguing they could eliminate the energy layer switching bottleneck and enable ultra-fast, higher-quality treatments.","lead":"This review paper argues that proton therapy is slowed by the time it takes to switch between beam energy layers, and proposes that redesigning beam delivery systems to accept a wide range of energies at once could enable ultra-fast treatments. It surveys existing large-energy-acceptance (LEA) beamline designs and their potential clinical benefits.","discovery_kind":"review","skeptic_critique":{"model":"deepseek-v4-flash","headline":"LEA clinical benefits hinge on unverified beam quality across the acceptance range; the paper's own section 4.1 acknowledges this gap.","rationale":"The reader's weakest_assumption correctly identifies beam quality as the central risk: the clinical benefits claimed for LEA BDS are credible only if the delivered beam stays within clinical tolerances. The paper itself repeatedly flags this as an open problem (e.g., 'A challenge for most LEA designs... is the beam distortion caused by nonlinear and higher order effects' in Section 4.1; 'very little currently exists in literature' on LEA-specific dosimetric impact). Table 2 corroborates that most LEA proposals achieve only geometric, not optical, achromaticity, implying energy-dependent spot size and shape. This is not a flaw in the review—the authors are transparent about it—but it is the most load-bearing assumption in the central claim. The review's value as a synthesis is unaffected, so the ACCEPT verdict stands; no change is needed.","tokens_in":37003,"tokens_out":7814,"duration_ms":76300,"concrete_test":"Perform an end-to-end simulation for a representative LEA design, e.g., Nesteruk et al. (2019). Track a realistic beam (including degrader energy spread and emittance) through the full magnet lattice using simulated or measured field maps with multipole errors. Extract spot size, shape, and centroid at isocentre for all energies in the acceptance range and several scan angles. Then implement these energy-dependent beam models in a treatment planning system and compare a moving-target plan (e.g., lung) against a conventional BDS plan, scoring CTV coverage, homogeneity, and normal-tissue sparing. If the LEA plan fails TG-224 tolerance or shows degraded dosimetric quality, the central clinical claim is undermined.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The central claim that a LEA BDS can enable ultra-fast delivery with immediate clinical benefits depends on the assumption that the delivered beam meets clinical quality standards (spot size, shape, position) across the entire energy acceptance. The paper explicitly identifies the risk in Section 4.1: nonlinear and higher-order fields in most LEA proposals distort the beam into non-circular, asymmetric, energy-dependent spots. Table 2 shows that among the reviewed designs, only one (Brouwer et al.) claims full optical achromaticity, and that design relies on fast-ramping quadrupoles, partially reintroducing the switching bottleneck the paper aims to eliminate. The paper also states that 'very little currently exists in literature' on LEA-specific planning/dosimetric impact, and notes that standard treatment planning systems assume circular Gaussian spots. Without an end-to-end demonstration that such distorted, energy-dependent beams can be accurately modeled and delivered within AAPM TG-224 tolerances (±1 mm position, ±10% size), the claimed dosimetric benefits (reduced interplay, sharper gradients, volumetric rescanning) could be offset by systematic dose errors. This assumption is load-bearing because the entire clinical‐adoption case rests on maintaining beam quality at isocentre across the full range of energies and scanning angles.","agreement_with_reader":"agree"},"referee_report":{"model":"deepseek-v4-flash","summary":"This review article argues that the energy layer switching time (ELST) remains a major bottleneck in proton beam therapy (PBT), and that a beam delivery system (BDS) designed with a large energy/momentum acceptance could minimize or eliminate this bottleneck, enabling 'ultra-fast' delivery. The paper reviews clinical motivations (shorter treatments, reduced motion/degradation, improved rescanning, volumetric rescanning, bidirectional delivery, arc therapy, FLASH), surveys proposed LEA beamline designs (Keil, Fenning, Wan, Brouwer, Nesteruk, GaToroid, Trbojevic, Dascalu/Sheehy, Liao, TURBO), compares their geometric and optical achromaticity, discusses magnet technologies, and examines clinical implementation issues, particularly beam quality. It is a review rather than original research; its claims are supported by cited literature, and it explicitly identifies open challenges and the lack of constructed LEA systems.","tokens_in":37288,"tokens_out":7074,"duration_ms":69736,"significance":"If the LEA concept is realized, it could transform PBT delivery by removing a recognized technological bottleneck and enabling emerging delivery modalities. The review is timely, comprehensive, and technically informed, providing a clear distinction between geometric and optical achromaticity and a useful comparison table. It is appropriately cautious: it repeatedly notes that no LEA BDS has been built, that most designs suffer from nonlinear-field beam distortion, and that very little exists in the literature on LEA-specific planning/dosimetric impact (Section 4.1). The paper also correctly states that full exploitation of a LEA BDS requires an accelerator capable of rapid energy variation. While the clinical benefits are contingent on solving beam-quality and dosimetric-modeling challenges, the review does not overclaim; it frames these as open problems. The manuscript is a valuable resource for the field and a credible case for further R&D.","major_comments":[],"minor_comments":[{"comment":"In the paragraph on Keil et al., the phrase 'the drifts appear appear much shorter than the magnets' contains a duplicated word ('appear appear'). Please revise.","section":"3.1.2"},{"comment":"Affiliation 6 contains a typographical error: 'T echnology' should read 'Technology'.","section":"Affiliation"},{"comment":"Reference [168] is cited as a dataset. If the beamline parameters (1.23-2.32 Tm, 70-230 MeV) are drawn from a peer-reviewed publication, please cite that source instead or in addition to the dataset.","section":"Table 2 / Reference [168]"},{"comment":"The caption states 'Figures pending copyright permissions.' For a published review, permissions must be secured before publication; please ensure that all copyrighted figures are reproduced with explicit permission, consistent with the statement in the caption of Figure 2.","section":"Figure 10 caption"},{"comment":"The sentence 'A LEA BDS which does not need to rely successive magnetic field changes for each IES on may offer better stability' contains a grammatical error. Suggested revision: '...does not need to rely on successive magnetic field changes for each IES may offer better stability...'.","section":"4.1.1"}],"recommendation":"minor_revision","confidential_remarks":"This is a competent and well-balanced review. I found no technical errors in the survey or argumentation. The main risk is that the conclusion 'the clinical potential and benefits of this enabling technology are clear' may be slightly stronger than the evidence justifies, but the manuscript itself supplies the relevant caveats in Sections 4.1 and 5. The self-citations are appropriate given the authors' direct contributions to LEA beamline design (e.g., TURBO). The paper fits the journal's scope and is publishable after minor editorial corrections."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"You should know two things before reading this one. First, it is a well-executed review, not a new result. That is fine; the review is needed. It compiles the scattered LEA beamline proposals (KST, Fenning, GaToroid, Nesteruk, TURBO, etc.) into one place, adds a genuinely helpful comparison table, and crisply separates geometric from optical achromaticity. Second, the clinical enthusiasm in the framing is stronger than the underlying evidence. Words like \"revolutionise\" and \"the complete exploitation of PBT ... can only be made possible\" are promotional, and the paper would be better without them. But that is a framing problem, not a load-bearing flaw.\n\nWhat the paper does well: it correctly identifies ELST as a real bottleneck, with the supporting timing studies cited properly. It gives a fair and detailed survey of the design space, including the trade-offs and unbuilt status of every proposal. It is candid about the open challenges, especially beam distortion from nonlinear fields and the lack of end-to-end dosimetric studies. The authors have their own horse in the race (TURBO), but they cite competing designs fairly and do not overstate the maturity of their own work. The central argument—that increasing beamline momentum acceptance would reduce ELST and enable faster delivery—holds up as a review-level claim.\n\nThe soft spots are proportionate. The weakest link is the beam-quality assumption: Table 2 shows only one design claims full optical achromaticity, and that one partially reintroduces ramping. The paper itself acknowledges in Section 4.1 that many LEA designs produce non-circular, asymmetric, energy-dependent spots, and that very little exists on LEA-specific planning. The reader's stress-test concern lands, but it lands on the field, not on this paper. A review should flag that gap, and this one does. What it should not do is then claim the clinical benefits are \"clear\" in the summary. That overreach is fixable with softening language.\n\nThe citation pattern looks sound. The paper leans on primary sources for ELST data and clinical claims, and the discussion of both supporting and limiting studies is balanced. No signs of circularity beyond the normal self-citation you expect from an active group.\n\nWho is this for? Anyone working on PBT delivery systems, accelerator physics for therapy, or treatment planning for fast delivery. It deserves a serious referee. I would send it to peer review and accept after minor revisions that temper the promotional language and make the beam-quality caveat more prominent in the abstract and summary.","headline":"A genuinely useful review of large energy acceptance beam delivery for proton therapy, but the clinical-benefit framing runs ahead of the evidence and the beam-quality gap is real, though honestly acknowledged.","tokens_in":37822,"tokens_out":1251,"would_cite":true,"duration_ms":18024,"reading_group":"yes","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"Widening beamline energy acceptance would remove the slowest step in proton therapy and unlock ultra-fast delivery.","keywords":["proton beam therapy","charged particle therapy","beam delivery","large energy acceptance","rapid delivery","novel delivery modalities","compact facilities","energy layer switching time"],"falsifier":"Measure the delivered spot size and shape in a prototype large-energy-acceptance beamline across the full 70–230 MeV range at clinical intensity and scanning angles; if distortion or energy-dependent variation exceeds the ±10% size / ±1 mm position tolerances cited in the paper, the claimed treatment-quality and motion-mitigation advantages would fail to materialize.","tokens_in":36892,"feed_emoji":"⚡","tokens_out":5030,"duration_ms":48035,"temperature":0.7,"pith_summary":"Proton beam therapy is slowed by the energy layer switching time — the wait while magnets re-tune before each new depth layer. The paper argues this bottleneck is a design choice, not a law of physics: conventional beamlines accept only about 0.5–1% momentum spread, so every energy change forces a full magnet re-ramp. If the beamline were built to accept a wide energy band at fixed magnet settings, switching time could drop by orders of magnitude, enabling ultra-fast delivery. The authors survey a decade of large-energy-acceptance beamline designs and argue that the clinical payoff — shorter treatments, less motion-induced dose error, practical rescanning, and future arc and FLASH therapy — follows directly from this one change.","feed_headline":"A wider energy window could make proton therapy ultra-fast","feed_subtitle":"Wider beamline energy acceptance removes the wait between depth layers, enabling faster, motion-robust treatments.","key_machinery":"The central object is the large energy acceptance (LEA) beamline: a beam transport and delivery system whose momentum acceptance spans tens of percent rather than the conventional ~0.5–1%. The key identity is the relationship between beamline momentum acceptance and the energy layer switching time: when acceptance is small, every change in beam energy requires synchronous re-ramping of all magnets to a new field setting; when acceptance is large, a fixed magnet setting transports a wide range of energies, so the ELST collapses toward the mechanical speed of the degrader and the control-system latency. The paper frames the design requirements as geometric achromaticity (all momenta converge a","core_discovery":"The paper's central claim is that the energy layer switching time — the wait between successive depth layers during pencil beam scanning — is a fundamental constraint imposed by the narrow momentum acceptance (about 0.5–1%) of current beam delivery systems, and that this constraint can be removed by designing beamlines with a large energy acceptance (tens of percent). With a large-energy-acceptance beamline, magnets no longer need to be re-ramped for each energy layer, because a single magnet setting transports the full energy range; only a degrader or accelerator setting must change. The authors argue this eliminates the dominant component of beam delivery time, leading to ultra-fast delive","pith_inferences":["The review's logic implies that the accelerator choice (cyclotron versus synchrotron) becomes less decisive for treatment speed; the beamline becomes the rate-limiting component, so future R&D should shift from accelerator design to beamline acceptance and magnet technology.","A concrete testable prediction follows: if a clinical LEA beamline is built, measured spot-size energy dependence will need to stay within clinical tolerances across the full energy range; if it does not, plan quality and robustness will degrade and the dosimetric advantage over a well-tuned conventional system will shrink.","The paper's emphasis on transporting a large range of energies rather than a large energy spread suggests that LEA systems will still need energy-selection or collimation to control distal fall-off when the degrader produces a broad spectrum; without it, off-nominal energies could distort the depth-dose distribution.","If the technology matures, the cost model of proton therapy could shift: single-room facilities with a LEA beamline and a simpler accelerator may approach the size and cost of a conventional linac bunker, potentially making proton therapy a mainstream radiotherapy option rather than a specialized one."],"forward_implications":["If a LEA beamline is realized, the energy layer switching time could drop from hundreds of milliseconds or seconds to near the physical limits of the degrader and interlocks, reducing total beam delivery time by the 70–90% share that ELST currently contributes.","Ultra-fast delivery would make volumetric rescanning practical, allowing many repaints per breathing cycle and better averaging of respiratory motion.","Bidirectional energy delivery becomes possible without hysteresis re-ramping, enabling new planning optimizations and facilitating proton arc therapy and beam tracking.","Bragg-peak FLASH delivery, which requires whole-field irradiation within about a second, becomes feasible with a LEA beamline, whereas current ELSTs preclude it.","Shorter treatments reduce intrafraction motion, permit smaller planning margins, and increase patient throughput, directly improving treatment quality and cost-effectiveness."],"fun_headline_variants":["Wider energy window speeds up proton therapy","Large energy acceptance enables ultra-fast proton treatments","Beamline innovation eliminates energy-switch delays in proton therapy","Single magnet setting across energies speeds proton beam delivery"],"cache_read_input_tokens":2304,"weakest_assumption_plain":"The entire clinical case rests on a large-energy-acceptance beamline delivering circular, stable, energy-independent spots across the full therapeutic energy range within clinical tolerances; the paper itself flags that most proposals suffer nonlinear beam distortion and energy-dependent spot variation, so if that assumed beam quality is not met, the dosimetric benefits evaporate.","fun_headline_variants_meta":{"raw":{"variants":["Wider energy window speeds up proton therapy","Large energy acceptance enables ultra-fast proton treatments","Beamline innovation eliminates energy-switch delays in proton therapy","Single magnet setting across energies speeds proton beam delivery"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.000548,"raw_usage":{"total_tokens":2486,"prompt_tokens":810,"completion_tokens":1676,"prompt_tokens_details":{"cached_tokens":256},"prompt_cache_hit_tokens":256,"prompt_cache_miss_tokens":554,"completion_tokens_details":{"reasoning_tokens":1628}},"tokens_in":554,"tokens_out":1676,"duration_ms":16809,"temperature":1.0,"reasoning_tokens":1628,"cache_read_input_tokens":256,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-03T09:26:43.529402+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"Measure the delivered spot size and shape in a prototype large-energy-acceptance beamline across the full 70–230 MeV range at clinical intensity and scanning angles; if distortion or energy-dependent variation exceeds the ±10% size / ±1 mm position tolerances cited in the paper, the claimed treatment-quality and motion-mitigation advantages would fail to materialize.","supporting_citations":[],"review_version":1}